Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes

חו"ל (דורש נסיעה)מגייס משתתפים

מצבים רפואיים

Type 2 Diabetes Mellitus · Type2diabetes · Diabetes Mellitus, Type 2 · Diabetes · Type 2 Diabetes

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • University of Alabama, Birmingham, Alabama, United States

  • Central Alabama Research, Birmingham, Alabama, United States

  • Velocity Clinical Research, Gardena, Gardena, California, United States

  • Cedars-Sinai Medical Center, Los Angeles, California, United States

  • UCLA, Los Angeles, California, United States

  • Hoag Memorial Hospital Presbyterian - Digestive Health Institute, Newport Beach, California, United States

  • Velocity Clinical Research, Panorama City, Panorama City, California, United States

  • Velocity Clinical Research, Hallandale Beach, Hallandale, Florida, United States

  • Mayo Clinic, Jacksonville, Florida, United States

  • Universal Axon Clinical Research LLC, Miami, Florida, United States

  • University of Miami, Miami, Florida, United States

  • Quantum Clinical Research, Miami Beach, Florida, United States

  • West Orange Endocrinology, Ocoee, Florida, United States

  • Advent Health, Orlando, Florida, United States

  • Orlando Health, Orlando, Florida, United States

  • Health Synergy Clinical Research, West Palm Beach, Florida, United States

  • NorthShore University Health System, Evanston, Illinois, United States

  • Heartland Medical Research, Inc., Clive, Iowa, United States

  • Iowa Diabetes and Endocrinology Research Center, West Des Moines, Iowa, United States

  • John Hopkins, Baltimore, Maryland, United States

  • Mayo Clinic, Rochester, Minnesota, United States

  • Cooper Health System, Camden, New Jersey, United States

  • Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States

  • The Ohio State University- Wexner Medical Center, Columbus, Ohio, United States

  • Velocity Clinical Research - Austin, Austin, Texas, United States

  • Dell Medical School, Austin, Texas, United States

  • IMA Clinical Research - Austin, Austin, Texas, United States

  • The University of Texas Health Science Center at Houston, Bellaire, Texas, United States

  • Velocity Clinical Research, Dallas, Dallas, Texas, United States

  • Southwest Medical Center, Dallas, Texas, United States

  • University of Texas Southwestern Medical School - William P. Clements Jr. University Hospital, Dallas, Texas, United States

  • Epic Medical Research, DeSoto, Texas, United States

  • Houston Methodist Research Institute, Houston, Texas, United States

  • Juno Research, LLC, Houston, Texas, United States

  • Texas Diabetes & Endocrinology, P.A., Round Rock, Texas, United States

  • Diabetes & Glandular Disease Clinic, P.A., San Antonio, Texas, United States

  • IMA Clinical Research - San Antonio, San Antonio, Texas, United States

  • Mt. Olympus Medical Research, Sugar Land, Texas, United States

  • Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia

  • The BMI Clinic, Double Bay, New South Wales, Australia

  • Royal North Shore Hospital, Saint Leonards, New South Wales, Australia

  • Eastern Health - Box Hill Hospital, Box Hill, Victoria, Australia

  • St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia

  • Austin Health, Heidelberg, Victoria, Australia

  • Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia

מובילי המחקר
  • Lian Cunningham, MD, PhD

    Study Director

    lcunningham@endogenex.com